1-[(3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one;7-bromo-6-chloro-3H-quinazolin-4-one;7-bromo-4,6-dichloroquinazoline;tert-butyl (3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-(7-bromo-6-chloroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-[6-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-3-methylpiperazine-1-carboxylate;6-[6-chloro-4-[(2S)-2-methylpiperidin-1-yl]quinazolin-7-yl]-5-(trifluoromethyl)pyridin-2-amine;6-chloro-5-(trifluoromethyl)pyridin-2-amine;prop-2-enoic acid;sulfane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane

C155H192B3Br3Cl9F12N33O18S6 — CID 159060259

About 1-[(3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one;7-bromo-6-chloro-3H-quinazolin-4-one;7-bromo-4,6-dichloroquinazoline;tert-butyl (3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-(7-bromo-6-chloroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-[6-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-3-methylpiperazine-1-carboxylate;6-[6-chloro-4-[(2S)-2-methylpiperidin-1-yl]quinazolin-7-yl]-5-(trifluoromethyl)pyridin-2-amine;6-chloro-5-(trifluoromethyl)pyridin-2-amine;prop-2-enoic acid;sulfane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane

1-[(3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one;7-bromo-6-chloro-3H-quinazolin-4-one;7-bromo-4,6-dichloroquinazoline;tert-butyl (3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-(7-bromo-6-chloroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-[6-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-3-methylpiperazine-1-carboxylate;6-[6-chloro-4-[(2S)-2-methylpiperidin-1-yl]quinazolin-7-yl]-5-(trifluoromethyl)pyridin-2-amine;6-chloro-5-(trifluoromethyl)pyridin-2-amine;prop-2-enoic acid;sulfane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane (PubChem CID 159060259) has the molecular formula C155H192B3Br3Cl9F12N33O18S6 and a molecular weight of 3817.06 g/mol. Its IUPAC name is 1-[(3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one;7-bromo-6-chloro-3H-quinazolin-4-one;7-bromo-4,6-dichloroquinazoline;tert-butyl (3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-(7-bromo-6-chloroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-[6-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-3-methylpiperazine-1-carboxylate;6-[6-chloro-4-[(2S)-2-methylpiperidin-1-yl]quinazolin-7-yl]-5-(trifluoromethyl)pyridin-2-amine;6-chloro-5-(trifluoromethyl)pyridin-2-amine;prop-2-enoic acid;sulfane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane.

Molecular Properties

• Compound Name: 1-[(3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one;7-bromo-6-chloro-3H-quinazolin-4-one;7-bromo-4,6-dichloroquinazoline;tert-butyl (3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-(7-bromo-6-chloroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-[6-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-3-methylpiperazine-1-carboxylate;6-[6-chloro-4-[(2S)-2-methylpiperidin-1-yl]quinazolin-7-yl]-5-(trifluoromethyl)pyridin-2-amine;6-chloro-5-(trifluoromethyl)pyridin-2-amine;prop-2-enoic acid;sulfane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
• PubChem CID: 159060259
• Molecular Formula: C155H192B3Br3Cl9F12N33O18S6
• Molecular Weight: 3817.06 g/mol
• Exact Mass: 3807.83
• IUPAC Name: 1-[(3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one;7-bromo-6-chloro-3H-quinazolin-4-one;7-bromo-4,6-dichloroquinazoline;tert-butyl (3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-(7-bromo-6-chloroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-[6-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-3-methylpiperazine-1-carboxylate;6-[6-chloro-4-[(2S)-2-methylpiperidin-1-yl]quinazolin-7-yl]-5-(trifluoromethyl)pyridin-2-amine;6-chloro-5-(trifluoromethyl)pyridin-2-amine;prop-2-enoic acid;sulfane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
• SMILES: C=CC(=O)N1CCN(c2ncnc3cc(-c4nc(N)ccc4C(F)(F)F)c(Cl)cc23)[C@@H](C)C1.C=CC(=O)O.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.C[C@H]1CCCCN1c1ncnc2cc(-c3nc(N)ccc3C(F)(F)F)c(Cl)cc12.C[C@H]1CN(C(=O)OC(C)(C)C)CCN1.C[C@H]1CN(C(=O)OC(C)(C)C)CCN1c1ncnc2cc(-c3nc(N)ccc3C(F)(F)F)c(Cl)cc12.C[C@H]1CN(C(=O)OC(C)(C)C)CCN1c1ncnc2cc(B3OC(C)(C)C(C)(C)O3)c(Cl)cc12.C[C@H]1CN(C(=O)OC(C)(C)C)CCN1c1ncnc2cc(Br)c(Cl)cc12.Clc1cc2c(Cl)ncnc2cc1Br.Nc1ccc(C(F)(F)F)c(Cl)n1.O=c1[nH]cnc2cc(Br)c(Cl)cc12.S.S.S.S.S.S
• InChI: InChI=1S/C24H34BClN4O4.C24H26ClF3N6O2.C22H20ClF3N6O.C20H19ClF3N5.C18H22BrClN4O2.C12H24B2O4.C10H20N2O2.C8H3BrCl2N2.C8H4BrClN2O.C6H4ClF3N2.C3H4O2.6H2S/c1-15-13-29(21(31)32-22(2,3)4)9-10-30(15)20-16-11-18(26)17(12-19(16)27-14-28-20)25-33-23(5,6)24(7,8)34-25;1-13-11-33(22(35)36-23(2,3)4)7-8-34(13)21-15-9-17(25)14(10-18(15)30-12-31-21)20-16(24(26,27)28)5-6-19(29)32-20;1-3-19(33)31-6-7-32(12(2)10-31)21-14-8-16(23)13(9-17(14)28-11-29-21)20-15(22(24,25)26)4-5-18(27)30-20;1-11-4-2-3-7-29(11)19-13-8-15(21)12(9-16(13)26-10-27-19)18-14(20(22,23)24)5-6-17(25)28-18;1-11-9-23(17(25)26-18(2,3)4)5-6-24(11)16-12-7-14(20)13(19)8-15(12)21-10-22-16;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-8-7-12(6-5-11-8)9(13)14-10(2,3)4;9-5-2-7-4(1-6(5)10)8(11)13-3-12-7;9-5-2-7-4(1-6(5)10)8(13)12-3-11-7;7-5-3(6(8,9)10)1-2-4(11)12-5;1-2-3(4)5;;;;;;/h11-12,14-15H,9-10,13H2,1-8H3;5-6,9-10,12-13H,7-8,11H2,1-4H3,(H2,29,32);3-5,8-9,11-12H,1,6-7,10H2,2H3,(H2,27,30);5-6,8-11H,2-4,7H2,1H3,(H2,25,28);7-8,10-11H,5-6,9H2,1-4H3;1-8H3;8,11H,5-7H2,1-4H3;1-3H;1-3H,(H,11,12,13);1-2H,(H2,11,12);2H,1H2,(H,4,5);6*1H2/t15-;13-;12-;2*11-;;8-;;;;;;;;;;/m00000.0........../s1
• InChIKey: JYJJYCWDEOQZGC-MNOQCLFRSA-N
• XLogP: 36.18
• TPSA: 615.45 Ų
• H-Bond Donors: 7
• H-Bond Acceptors: 44
• Rotatable Bonds: 12
• Heavy Atoms: 239
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3817.06
LogP ≤ 5	36.18
H-Bond Donors ≤ 5	7
H-Bond Acceptors ≤ 10	44

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 1-[(3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one;7-bromo-6-chloro-3H-quinazolin-4-one;7-bromo-4,6-dichloroquinazoline;tert-butyl (3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-(7-bromo-6-chloroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-[6-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-3-methylpiperazine-1-carboxylate;6-[6-chloro-4-[(2S)-2-methylpiperidin-1-yl]quinazolin-7-yl]-5-(trifluoromethyl)pyridin-2-amine;6-chloro-5-(trifluoromethyl)pyridin-2-amine;prop-2-enoic acid;sulfane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?

The IUPAC name of 1-[(3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one;7-bromo-6-chloro-3H-quinazolin-4-one;7-bromo-4,6-dichloroquinazoline;tert-butyl (3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-(7-bromo-6-chloroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-[6-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-3-methylpiperazine-1-carboxylate;6-[6-chloro-4-[(2S)-2-methylpiperidin-1-yl]quinazolin-7-yl]-5-(trifluoromethyl)pyridin-2-amine;6-chloro-5-(trifluoromethyl)pyridin-2-amine;prop-2-enoic acid;sulfane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane (CID 159060259) is 1-[(3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one;7-bromo-6-chloro-3H-quinazolin-4-one;7-bromo-4,6-dichloroquinazoline;tert-butyl (3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-(7-bromo-6-chloroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-[6-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-3-methylpiperazine-1-carboxylate;6-[6-chloro-4-[(2S)-2-methylpiperidin-1-yl]quinazolin-7-yl]-5-(trifluoromethyl)pyridin-2-amine;6-chloro-5-(trifluoromethyl)pyridin-2-amine;prop-2-enoic acid;sulfane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane.

What is the SMILES notation for 1-[(3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one;7-bromo-6-chloro-3H-quinazolin-4-one;7-bromo-4,6-dichloroquinazoline;tert-butyl (3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-(7-bromo-6-chloroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-[6-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-3-methylpiperazine-1-carboxylate;6-[6-chloro-4-[(2S)-2-methylpiperidin-1-yl]quinazolin-7-yl]-5-(trifluoromethyl)pyridin-2-amine;6-chloro-5-(trifluoromethyl)pyridin-2-amine;prop-2-enoic acid;sulfane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?

The canonical SMILES for 1-[(3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one;7-bromo-6-chloro-3H-quinazolin-4-one;7-bromo-4,6-dichloroquinazoline;tert-butyl (3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-(7-bromo-6-chloroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-[6-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-3-methylpiperazine-1-carboxylate;6-[6-chloro-4-[(2S)-2-methylpiperidin-1-yl]quinazolin-7-yl]-5-(trifluoromethyl)pyridin-2-amine;6-chloro-5-(trifluoromethyl)pyridin-2-amine;prop-2-enoic acid;sulfane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane is C=CC(=O)N1CCN(c2ncnc3cc(-c4nc(N)ccc4C(F)(F)F)c(Cl)cc23)[C@@H](C)C1.C=CC(=O)O.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.C[C@H]1CCCCN1c1ncnc2cc(-c3nc(N)ccc3C(F)(F)F)c(Cl)cc12.C[C@H]1CN(C(=O)OC(C)(C)C)CCN1.C[C@H]1CN(C(=O)OC(C)(C)C)CCN1c1ncnc2cc(-c3nc(N)ccc3C(F)(F)F)c(Cl)cc12.C[C@H]1CN(C(=O)OC(C)(C)C)CCN1c1ncnc2cc(B3OC(C)(C)C(C)(C)O3)c(Cl)cc12.C[C@H]1CN(C(=O)OC(C)(C)C)CCN1c1ncnc2cc(Br)c(Cl)cc12.Clc1cc2c(Cl)ncnc2cc1Br.Nc1ccc(C(F)(F)F)c(Cl)n1.O=c1[nH]cnc2cc(Br)c(Cl)cc12.S.S.S.S.S.S.

What is the InChIKey of 1-[(3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one;7-bromo-6-chloro-3H-quinazolin-4-one;7-bromo-4,6-dichloroquinazoline;tert-butyl (3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-(7-bromo-6-chloroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-[6-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-3-methylpiperazine-1-carboxylate;6-[6-chloro-4-[(2S)-2-methylpiperidin-1-yl]quinazolin-7-yl]-5-(trifluoromethyl)pyridin-2-amine;6-chloro-5-(trifluoromethyl)pyridin-2-amine;prop-2-enoic acid;sulfane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?

The InChIKey is JYJJYCWDEOQZGC-MNOQCLFRSA-N. The full InChI is InChI=1S/C24H34BClN4O4.C24H26ClF3N6O2.C22H20ClF3N6O.C20H19ClF3N5.C18H22BrClN4O2.C12H24B2O4.C10H20N2O2.C8H3BrCl2N2.C8H4BrClN2O.C6H4ClF3N2.C3H4O2.6H2S/c1-15-13-29(21(31)32-22(2,3)4)9-10-30(15)20-16-11-18(26)17(12-19(16)27-14-28-20)25-33-23(5,6)24(7,8)34-25;1-13-11-33(22(35)36-23(2,3)4)7-8-34(13)21-15-9-17(25)14(10-18(15)30-12-31-21)20-16(24(26,27)28)5-6-19(29)32-20;1-3-19(33)31-6-7-32(12(2)10-31)21-14-8-16(23)13(9-17(14)28-11-29-21)20-15(22(24,25)26)4-5-18(27)30-20;1-11-4-2-3-7-29(11)19-13-8-15(21)12(9-16(13)26-10-27-19)18-14(20(22,23)24)5-6-17(25)28-18;1-11-9-23(17(25)26-18(2,3)4)5-6-24(11)16-12-7-14(20)13(19)8-15(12)21-10-22-16;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-8-7-12(6-5-11-8)9(13)14-10(2,3)4;9-5-2-7-4(1-6(5)10)8(11)13-3-12-7;9-5-2-7-4(1-6(5)10)8(13)12-3-11-7;7-5-3(6(8,9)10)1-2-4(11)12-5;1-2-3(4)5;;;;;;/h11-12,14-15H,9-10,13H2,1-8H3;5-6,9-10,12-13H,7-8,11H2,1-4H3,(H2,29,32);3-5,8-9,11-12H,1,6-7,10H2,2H3,(H2,27,30);5-6,8-11H,2-4,7H2,1H3,(H2,25,28);7-8,10-11H,5-6,9H2,1-4H3;1-8H3;8,11H,5-7H2,1-4H3;1-3H;1-3H,(H,11,12,13);1-2H,(H2,11,12);2H,1H2,(H,4,5);6*1H2/t15-;13-;12-;2*11-;;8-;;;;;;;;;;/m00000.0........../s1.

What are the key properties of 1-[(3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one;7-bromo-6-chloro-3H-quinazolin-4-one;7-bromo-4,6-dichloroquinazoline;tert-butyl (3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-(7-bromo-6-chloroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-[6-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-3-methylpiperazine-1-carboxylate;6-[6-chloro-4-[(2S)-2-methylpiperidin-1-yl]quinazolin-7-yl]-5-(trifluoromethyl)pyridin-2-amine;6-chloro-5-(trifluoromethyl)pyridin-2-amine;prop-2-enoic acid;sulfane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?

1-[(3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one;7-bromo-6-chloro-3H-quinazolin-4-one;7-bromo-4,6-dichloroquinazoline;tert-butyl (3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-(7-bromo-6-chloroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-[6-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-3-methylpiperazine-1-carboxylate;6-[6-chloro-4-[(2S)-2-methylpiperidin-1-yl]quinazolin-7-yl]-5-(trifluoromethyl)pyridin-2-amine;6-chloro-5-(trifluoromethyl)pyridin-2-amine;prop-2-enoic acid;sulfane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane has a molecular weight of 3817.06 g/mol, XLogP of 36.18, 12 rotatable bonds, 7 hydrogen bond donors, and 44 hydrogen bond acceptors.

Where does this data come from?

All data for 1-[(3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one;7-bromo-6-chloro-3H-quinazolin-4-one;7-bromo-4,6-dichloroquinazoline;tert-butyl (3S)-4-[7-[6-amino-3-(trifluoromethyl)-2-pyridinyl]-6-chloroquinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-(7-bromo-6-chloroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-4-[6-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl]-3-methylpiperazine-1-carboxylate;tert-butyl (3S)-3-methylpiperazine-1-carboxylate;6-[6-chloro-4-[(2S)-2-methylpiperidin-1-yl]quinazolin-7-yl]-5-(trifluoromethyl)pyridin-2-amine;6-chloro-5-(trifluoromethyl)pyridin-2-amine;prop-2-enoic acid;sulfane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane is sourced from PubChem (CID 159060259), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).